- Home
- PBT vs CDXC Comparison
PBT vs CDXC Comparison
Compare PBT & CDXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBT
- CDXC
- Stock Information
- Founded
- PBT 1980
- CDXC 1999
- Country
- PBT United States
- CDXC United States
- Employees
- PBT N/A
- CDXC N/A
- Industry
- PBT Oil & Gas Production
- CDXC Medicinal Chemicals and Botanical Products
- Sector
- PBT Energy
- CDXC Health Care
- Exchange
- PBT Nasdaq
- CDXC Nasdaq
- Market Cap
- PBT 558.4M
- CDXC 449.5M
- IPO Year
- PBT N/A
- CDXC N/A
- Fundamental
- Price
- PBT $11.08
- CDXC $5.42
- Analyst Decision
- PBT
- CDXC Strong Buy
- Analyst Count
- PBT 0
- CDXC 2
- Target Price
- PBT N/A
- CDXC $8.00
- AVG Volume (30 Days)
- PBT 102.3K
- CDXC 338.3K
- Earning Date
- PBT 01-01-0001
- CDXC 03-05-2025
- Dividend Yield
- PBT 4.59%
- CDXC N/A
- EPS Growth
- PBT 25.21
- CDXC N/A
- EPS
- PBT 0.78
- CDXC 0.02
- Revenue
- PBT $37,735,284.00
- CDXC $91,668,000.00
- Revenue This Year
- PBT N/A
- CDXC $18.64
- Revenue Next Year
- PBT N/A
- CDXC $20.72
- P/E Ratio
- PBT $14.18
- CDXC $275.46
- Revenue Growth
- PBT 25.46
- CDXC 9.95
- 52 Week Low
- PBT $10.14
- CDXC $1.48
- 52 Week High
- PBT $14.58
- CDXC $7.97
- Technical
- Relative Strength Index (RSI)
- PBT 46.43
- CDXC 41.57
- Support Level
- PBT $10.69
- CDXC $5.38
- Resistance Level
- PBT $11.89
- CDXC $6.06
- Average True Range (ATR)
- PBT 0.37
- CDXC 0.22
- MACD
- PBT 0.06
- CDXC 0.00
- Stochastic Oscillator
- PBT 32.50
- CDXC 5.88
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.
About CDXC ChromaDex Corporation
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.